Efficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC)

  1. Gajate Borau, P.
  2. Martin Marino, A.
  3. Gallegos Sancho, I.
  4. Villa Guzman, J.C.
  5. Velastegui, A.
  6. Alonso Gordoa, T.
  7. Castellano, D.
  8. Rubio Romero, G.
  9. Pinto Marin, A.
  10. Villalobos Leon, L.
  11. Maximiano Alonso, C.
  12. Sotelo-Lezama, M.J.
  13. Sereno Moyano, M.
  14. Rodríguez, J.F.
  15. Perezagua Marin, C.
  16. Ballesteros, J.
  17. Marrupe Gonzalez, D.
  18. Rodriguez Lajusticia, L.
  19. Tafalla García, J.J.
  20. Aguado, C.
Revue:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Année de publication: 2018

Volumen: 29

Pages: viii286

Type: Article

DOI: 10.1093/ANNONC/MDY284.032 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus